Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-04

Clinical Trial Update: Role of the Gut Vascular Barrier and Microbiota in Autism Spectrum Disorders [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial examining the role of the gut vascular barrier and gut microbiota in autism spectrum disorders is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | Conditions: Autism, Autism Disorder | Phase 2, Phase 3 | Status: RECRUITING